FDA: Two More Eyedrop Brands Recalled Due To Risks

Two more eyedrop recalls owing to contamination risks are being announced by US health officials.

US health officials are warning consumers about two further recalls of eyedrops because of the possibility of contamination, which might result in significant damage or visual difficulties.

The announcements follow a recall last month of eyedrops made in India that were connected to an epidemic of drug-resistant diseases. At least five additional people had irreversible eyesight loss, and one individual passed away.

There is no evidence that the most recent recalls are connected to those goods.

Following the firms’ announcements that they are voluntarily removing numerous batches of their goods from the market, the Food and Drug Administration published separate recall notifications for specific eyedrops marketed by Pharmedica and Apotex. Both businesses claimed that the FDA was consulted prior to conducting the recalls.

As a consequence of issues “that potentially result in blindness,” Pharmedica said on Friday that it is recalling two lots of its Perfectly Soothing 15% MSM Drops. The over-the-counter drops are made to soothe itchy eyes. The Phoenix-based company advised customers to cease using the drops right away and send them back to the shop where they were bought.

The recall involves almost 2,900 bottles, according to the business. Arizonan manufacturers produced the drops.

The FDA published a second recall notice from Apotex last week about the recall of six lots of prescription eyedrops used to treat a type of glaucoma. The business claimed that it started the recall after discovering cracks in a few bottle caps.

The 0.15% Brimonidine Tartrate Ophthalmic Solution eye drops were available from April 2017 through February 2018.

The eyedrops were made in Canada, according to a statement from Apotex in an email. There have been no complaints of injuries associated with the drops, according to the business.

Written by Muhammad Qasim